SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense volatility, with the community actively debating whether the token is primed for a massive short squeeze or trapped in a persistent pump-and-dump cycle. Retail traders remain deeply divided, with some aggressively loading up on dips while others express concerns over potential manipulation and a lack of official communication.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is currently attracting significant attention due to its pending merger with Agility Robotics, a move that has sparked intense debate among community members regarding its long-term potential versus concerns of a pump-and-dump scheme. Investors are actively discussing the company's backing by major technology and industrial giants, weighing the risks of SPAC-related volatility against the speculative appeal of the emerging humanoid robotics sector.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp. is trending as investors debate the company's progress in establishing domestic rare earth magnet processing capabilities to bypass Chinese supply chains, a move central to upcoming defense sourcing mandates. While some community members highlight the potential for long-term growth driven by federal procurement policy and strategic infrastructure investments, others express caution regarding potential market manipulation and the execution risks associated with scaling operations.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as investors focus on its role in the AI-agent infrastructure space, with many in the community highlighting the protocol's chain abstraction and recent developments in privacy-preserving technology. While some traders are capitalizing on high volatility with short-term strategies, long-term holders remain active, weighing the potential for utility-driven growth against broader market corrections.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock shares faced a sharp sell-off as the asset manager capped withdrawals from its private credit fund following redemption requests that exceeded the quarterly limit. The community is actively debating the health of the broader private credit sector, with investors drawing comparisons to past liquidity crises while others monitor potential contagion risks across alternative asset managers.

Bullish engages in the management of a digital asset platform. It also offers market infrastructure and information services. The company was founded by Brendan Francis Blumer in 2020 and is headquartered in George Town, Cayman Islands.

Bullish

Bullish is trending as investors weigh its aggressive expansion, including the acquisition of Equiniti, against significant volatility in crypto markets and mixed earnings reports. The community remains deeply divided, with some investors betting on the stock as a long-term infrastructure play backed by institutional accumulation, while critics express frustration over the stock's persistent downward trend since its IPO.

Jabil, Inc. engages in the provision of manufacturing services and solutions. It operates through the Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services (DMS) segments. The EMS segment focuses on leveraging information technology, supply chain design and engineering, technologies largely centered on core electronics, utilizing a large-scale manufacturing infrastructure, and the ability to serve a broad range of end markets. The DMS segment offers engineering solutions with an emphasis on material sciences, machining, tooling, and molding of engineered plastic and metal parts. The company was founded by William E. Morean and James Golden in 1966 and is headquartered in St. Petersburg, FL.

Jabil Inc

Jabil Inc. is trending as investors digest strong fiscal quarterly results that topped expectations and a new billion-dollar share repurchase authorization. The stock is drawing significant attention from the community due to its pivotal role as a hardware backbone for AI data center infrastructure and cloud expansion, keeping sentiment bullish as the company navigates stabilizing demand across its diverse end-markets.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors rotate into defensive healthcare stocks, further fueled by highly positive phase 3 data for its obesity drug retatrutide. The community is actively discussing the company's aggressive acquisition strategy, its competitive lead in the GLP-1 sector, and the potential for long-term growth as capital shifts away from high-beta technology shares.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is currently a major focus for investors as the community eagerly awaits a potential China carve-out to stabilize the balance sheet and bolster liquidity. Despite concerns over debt and share price performance, there is significant enthusiasm surrounding the company's expansion into new product categories like matcha and cold foam, which many hope will drive the next wave of profitable growth.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending as investors weigh strong earnings growth and a robust shift toward value-added services against regulatory pressure from proposed credit card interest rate caps and interchange fee legislation. While some in the community see the current volatility as a discount opportunity for a resilient compounder, others remain cautious due to ongoing institutional uncertainty and debates over the long-term impact of AI-driven payment solutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Rating Upgraded by Guggenheim

Guggenheim upgraded Corbus Pharmaceuticals to a "strong-buy" rating in a research report on Wednesday...

Corbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on Tuesday

Corbus Pharmaceuticals (NASDAQ:CRBP) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-corbus-pharmaceuticals-holdings-inc-stock...

Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Crosses Above Fifty Day Moving Average   - Should You Sell?

Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Above 50-Day Moving Average - Should You Sell...

Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded by Wall Street Zen to "Sell" Rating

Wall Street Zen raised shares of Corbus Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research report on Saturday...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten research firms that are presently covering the...

Corbus Pharmaceuticals Holdings, Inc. $CRBP Stock Holdings Lifted by Aberdeen Group plc

Aberdeen Group plc lifted its position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) by 602.2% during the 4th quarter, according to the company in its most recent disclosure...

Corbus Pharma Aligns With FDA On Registration Path For CRB-701 In HNSCC And Cervical Cancer

(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical-stage company, Tuesday announced that it broadly aligned with the FDA on the registration path for CRB-701, a highly stable Nectin-4 targeting ADC, in head and neck squamous cell carcinoma (HNSCC) and cervical c...

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Crosses Above 50-Day Moving Average - Time to Sell?

Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Pass Above 50 Day Moving Average - What's Next...

HC Wainwright Issues Negative Forecast for CRBP Earnings

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Research analysts at HC Wainwright dropped their Q1 2026 earnings estimates for shares of Corbus Pharmaceuticals in a research...

How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%

The mean of analysts' price targets for Corbus Pharmaceuticals (CRBP) points to a 318.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Corbus Pharmaceuticals Holdings Inc

CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.26	--	--	N/A
Q1 '26	-$1.22	-$1.23	-0.78%	MISSED
Q4 '25	-$1.52	-$1.25	17.64%	BEAT
Q3 '25	-$1.66	-$1.90	-14.69%	MISSED
Q2 '25	-$1.50	-$1.44	3.73%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRBPCorbus Pharmaceuticals Holdings Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CRBP News